Bridgefront Capital LLC Acquires Shares of 2,949 Waters Corporation $WAT

Bridgefront Capital LLC bought a new position in Waters Corporation (NYSE:WAT) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 2,949 shares of the medical instruments supplier’s stock, valued at approximately $884,000.

A number of other hedge funds also recently made changes to their positions in WAT. California Public Employees Retirement System grew its holdings in Waters by 4.8% during the 3rd quarter. California Public Employees Retirement System now owns 110,960 shares of the medical instruments supplier’s stock valued at $33,267,000 after buying an additional 5,092 shares in the last quarter. Bank of America Corp DE raised its holdings in shares of Waters by 4.3% during the 3rd quarter. Bank of America Corp DE now owns 543,149 shares of the medical instruments supplier’s stock worth $162,842,000 after acquiring an additional 22,586 shares in the last quarter. Bank of Nova Scotia boosted its position in shares of Waters by 17.8% during the 3rd quarter. Bank of Nova Scotia now owns 7,328 shares of the medical instruments supplier’s stock valued at $2,197,000 after acquiring an additional 1,105 shares during the last quarter. Beck Mack & Oliver LLC grew its holdings in shares of Waters by 58.5% in the third quarter. Beck Mack & Oliver LLC now owns 395,026 shares of the medical instruments supplier’s stock valued at $118,433,000 after purchasing an additional 145,838 shares in the last quarter. Finally, Boothbay Fund Management LLC grew its holdings in shares of Waters by 101.0% in the third quarter. Boothbay Fund Management LLC now owns 1,956 shares of the medical instruments supplier’s stock valued at $586,000 after purchasing an additional 983 shares in the last quarter. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Waters Stock Up 1.1%

Shares of WAT opened at $286.42 on Monday. The company has a market cap of $28.10 billion, a PE ratio of 26.59, a P/E/G ratio of 1.97 and a beta of 1.20. The business has a fifty day moving average of $352.67 and a 200 day moving average of $351.58. Waters Corporation has a 52-week low of $275.05 and a 52-week high of $414.15. The company has a quick ratio of 1.27, a current ratio of 1.73 and a debt-to-equity ratio of 0.37.

Waters (NYSE:WAT) last posted its quarterly earnings data on Monday, February 9th. The medical instruments supplier reported $4.53 earnings per share for the quarter, beating analysts’ consensus estimates of $4.50 by $0.03. Waters had a net margin of 20.30% and a return on equity of 34.79%. The business had revenue of $932.36 million for the quarter, compared to analysts’ expectations of $928.17 million. During the same quarter in the previous year, the business posted $4.10 earnings per share. The business’s revenue was up 6.9% compared to the same quarter last year. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. On average, sell-side analysts expect that Waters Corporation will post 12.86 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Robert W. Baird set a $363.00 price target on shares of Waters in a research note on Tuesday, February 10th. Guggenheim reissued a “buy” rating and issued a $440.00 price objective on shares of Waters in a research note on Tuesday, February 10th. Wall Street Zen downgraded shares of Waters from a “buy” rating to a “hold” rating in a report on Sunday, February 8th. HSBC started coverage on shares of Waters in a research report on Tuesday, January 27th. They set a “buy” rating and a $460.00 target price on the stock. Finally, Bank of America lowered their price target on shares of Waters from $410.00 to $350.00 and set a “neutral” rating for the company in a report on Tuesday, February 10th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $393.84.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.